Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor α transcription factor

Molecular Pharmacology

Volumn 67, Issue 4, 2005, Pages 1257-1267

  Fang, Hai Lin ^a   Strom, Stephen C ^b   Cai, Hongbo ^b   Falany, Charles N ^c   Kocarek, Thomas A ^a   Runge Morris, Melissa ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHOLESTEROL; CIPROFIBRATE; HYDROXYSTEROID; HYDROXYSTEROID SULFOTRANSFERASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; PREGNANE X RECEPTOR; XENOBIOTIC AGENT;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL STRAIN HEPG2; CHOLESTEROL LIVER LEVEL; CHROMATIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN GENOME; IMMUNOPRECIPITATION; LIVER CELL CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CLOFIBRIC ACID; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIVER; MOLECULAR SEQUENCE DATA; PPAR ALPHA; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOID X RECEPTORS; SULFOTRANSFERASES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 15744395646     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.005389     Document Type: Article

References (39)

1. Barbier O, Duran-Sandoval D, Pineda-Torra I, Kosykh V, Fruchart J-C, and Staels B (2003) Peroxisome proliferator-activated receptor α induces hepatic expression of the human bile acid glucuronidating UDP- glucuronosyltransferase 2B4 enzyme. J Biol Chem 278:32852-32860.
2. Barrero MJ, Camarero N, Marrero PF, and Haro D (2003) Control of human carnitine palmitoyltransferase II gene transcription by peroxisome proliferator-activated receptor through a partially conserved peroxisome proliferator-responsive element. Biochem J 369:721-729.
3. Blanchard RL, Freimuth RR, Buck J, Weinshilboum RM, and Coughtrie MWH (2004) A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 14:199-211.
4. Chen G, Zhang D, Jing N, Yin S, Falany CN, and Radominska-Pandya A (2003) Human gastrointestinal sulfotransferases; identification and distribution. Toxicol Appl Pharmacol 187:186-197.
5. Cheung C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C, and Gonzalez FJ (2004) Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor α. Cancer Res 64: 3849-3854.
6. Chu X-Y, Huskey S-EW, Braun MP, Sarkadi B, Evans DC, and Evers R (2004) Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2 and MRP3. J Pharmacol Exper Ther 309:156-164.
7. Dowell P, Ishmael JE, Avram D, Peterson VJ, Nevrivy DJ, and Leid M (1999) Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor α interacting protein. J Biol Chem 274:15901-15907.
8. Duanmu Z, Locke D, Smigelski J, Wu W, Dahn MS, Falany CN, Kocarek TA, and Runge-Morris M (2002) Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metab Dispos 30:997-1004.
9. Falany CN, Comer KA, Dooley TP, and Glatt H (1995) Human dehydroepiandrosterone sulfotransferase. Purification, molecular cloning and characterization. Ann NY Acad Sci 774:59-72.
10. Falany CN, Vazquez ME, and Kalb JM (1989) Purification and characterization of human liver dehydroepiandrosterone sulphotransferase. Biochem J 260:641-646.
11. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, et al. (1987) Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, incidences of coronary heart disease. N Engl J Med 317:1237-1245.
12. Gbaguidi GF and Agellon LB (2004) The inhibition of the human cholesterol 7α-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver x receptor α and peroxisome proliferator-activated receptor α heterodimer. Nucleic Acids Res 32:1113-1121.
13. Glatt H, Pauly K, Czich A, Falany JL, and Falany CN (1995) Activation of benzylic alcohols to mutagens fay rat and human sulfotransferases expressed in Escherichia coli. Eur J Pharmacol 293:173-181.
14. Kocarek TA, Dahn MS, Cai H, Strom SC, and Mercer-Haines NA (2002) Regulation of CYP2B6 and CYP3A expression by hydroxymethylglutaryl coenzyme A inhibitors in primary cultured human hepatocytes. Drug Metab Dispos 30:1400-1405.
15. Kocarek TA and Mercer-Haines NA (2002) Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor. Mol Pharmacol 62:1177-1186.
16. Lee C-H, Olson P, and Evans RM (2003) Minireview: lipid metabolism, metabolic diseases and peroxisome proliferator-activated receptors. Endocrinology 144: 2201-2207.
17. Mukherjee R, Sun S, Santomenna L, Miao B, Walton H, Liao B, Locke K, Zhang J-H, Nguyen SH, Zhang LT, et al. (2002) Ligand and coactivator recruitment preferences of peroxisome proliferator activated α. J Steroid Biochem Mol Biol 81:217-225.
18. Post SM, Duez H, Gervois PP, Staels B, Kuipers F, and Princen HMG (2001) Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-α-mediated downregulation of cholesterol 7α-hydroxylase and sterol 27-hydroxylase expression. Arterioscler Thromb Vasc Biol 21:1840-1845.
19. Quandt K, Frech K, Kara H, Wingender E, and Werner T (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23:4878-4884.
20. Rao MS and Reddy JK (1996) Hepatocarcinogenesis of peroxisome proliferators. Ann NY Acad Sci 804:573-587.
21. Rehman KS, Carr BR, and Rainey WE (2003) Profiling the steroidogenic pathway in human fetal and adult adrenals. J Soc Gynecol Investig 10:372-380.
22. Reyes H and Sjovall J (2000) Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 32:94-106.
23. Richert L, Lamboley C, Viollon-Abadie C, Grass P, Hartmann N, Laurent S, Heyd B, Mantion G, Chibout S-D, and Staedtler F (2003) Effects of clofibric acid on mRNA expression in primary cultures of rat, mouse and human hepatocytes. Toxicol Appl Pharmacol 191:130-146.
24. Runge-Morris M, Rose K, and Kocarek TA (1996) Regulation of hepatic sulfotransferase gene expression by glucocorticoid hormones. Drug Metab Dispos 24:1095-1101.
25. Runge-Morris M, Wu W, and Kocarek TA (1999) Regulation of rat hepatic hydroxysteroid sulfotransferase (SULT2-40/41) gene expression by glucocorticoids: evidence for a dual mechanism of transcription control. Mol Pharmacol 56:1198-1206.
26. Shang Y, Hu X, DiRenzo J, Lazar MA, and Brown M (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.
27. Shenoy SD, Spencer TA, Mercer-Haines NA, Alipour M, Gargano MD, Runge-Morris M, and Kocarek TA (2004) CYP3A induction by liver X receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor. Drug Metab Dispos 32:66-71.
28. Sinai CJ, Tohkin M, Miyata M, Ward JM, Lambert G, and Gonzalez FJ (2000) Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102:731-744.
29. Solass K, Kase BF, Pham V, Bamberg K, Hunt MC, and Alexson SEH (2004) Differential regulation of cytosolic and peradsomal bile acid amidation by PPARα activation favors the formation of unconjugated bile acids. J Lipid Res 45:1051-1060.
30. Song CS, Echchgadda I, Baek B-S, Ahn SC, Oh T, Roy AK, and Chatterjee B (2001) Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. J Biol Chem 276:42549-42556.
31. Sonoda J, Xie W, Rosenfeld JM, Barwick JL, Guzelian PS, and Evans RM (2002) Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci USA 99:13801-13806.
32. Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie K, LaTour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, et al. (2001) The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98:3369-3374.
33. Strassburg CP, Kneip S, Topp J, Obermeyer-Straub P, Barut A, Tukey RH, and Mann MP (2000) Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine. J Biol Chem 275:36164-36171.
34. Sugden MC and Holness MJ (2004) Potential role of peroxisome proliferator-activated receptor-alpha in the modulation of glucose-stimulated insulin secretion. Diabetes 53:S71-S81.
35. Torra IP, Claudel T, Duval C, Kosykh V, Frachart J-C, and Staels B (2003) Bile acids induce the expression of the human peroxisome proliferator-activated receptor α gene via activation of the farnesoid X receptor. Mol Endocrinol 17:259-272.
36. Vega RB, Huss JM, and Kelly DP (2000) The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 20: 1868-1876.
37. Wallberg AE, Yamamura S, Malik S, Spiegelman BM, and Roeder BM (2003) Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1α. Mol Cell 12:1137-1149.
38. Wang H, Chen J, Hollister K, Sowers LC, and Forman BM (1999) Endogenous bile acids are ligands for the nuclear receptor FXR. Mol Cell 3:543-553.
39. Yamazoe Y, Nagata K, Ozawa S, and Kato R (1994) Structural similarity and diversity of sulfotransferases. Chem Biol Interact 92:107-117.